FRUSCIO ROBERT

Alviano, A., Pagni, F., Seminati, D., Casati, G., Jaconi, M., Fruscio, R., et al. (2026). Validation of QuANTUM-derived tumor cell fraction for molecular testing in high-grade serous tubo-ovarian carcinoma. NPJ PRECISION ONCOLOGY [10.1038/s41698-026-01414-0]. Detail

Becherini, C., Blondeaux, E., Delucchi, V., Visani, L., Kim, H., Coussy, F., et al. (2026). Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study. RADIOTHERAPY AND ONCOLOGY, 219(June 2026) [10.1016/j.radonc.2026.111523]. Detail

Apostol, A., Gronwald, J., Cybulski, C., Kim, R., Møller, P., Karlan, B., et al. (2026). Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2. JOURNAL OF CLINICAL ONCOLOGY, 44(10), 883-892 [10.1200/JCO-25-01648]. Detail

Negri, S., Fornari, C., Ye, L., Inzoli, A., Costa, C., Mantovani, L., et al. (2026). Cost-effectiveness analysis (CEA) of ovarian cancer preventive strategies for women with BRCA1/2 pathogenic variants: the role of surveillance. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS [10.1007/s10198-026-01909-4]. Detail

Garzon, S., Campetti, E., Panzeri, M., Fumagalli, S., Nespoli, A., Locatelli, A., et al. (2026). Cross-Cultural Adaptation and Validation of KidSIM Attitude Towards Teamwork in Training Undergoing Designed Educational Simulation (ATTITUDES) in Undergraduate Healthcare Professionals. NURSING OPEN, 13(3) [10.1002/nop2.70499]. Detail